Authors: Sohrabi, F 1; Sohrabi, A 2; & Shmas-alizadeh, N 3.
1. M.Sc of Clinical psychology, University of Kurdistan, Sanandaj, Iran.,Email: F.email@example.com Mob: +98-9189926805
2. Psychologist. Department of psychology, Kurdistan university, Sanandaj, Iran. Email: Sohrabya@gmail.com
3. Psychiatrist, Department of psychiatry, Kurdistan University of medical sciences, Sanandaj, Iran. Email:Nshamsalizadeh@yahoo.com
This randomized controlled trial evaluated the effects of Mindfulness-integrated Cognitive Behavioral Therapy (MiCBT) on depression, adherence to medical treatment, and control of blood glucose in patients with Type II Diabetes Mellitus. Measures included the Beck Depression Inventory, the Adherence to Therapy Scale, and the Glucosilated Hemoglobin (HbA1c) test. Twenty-five patients who met the entrance criteria were randomly assigned to either the 8-session MiCBT program or a control condition. The results showed that participants who attended the MiCBT reported a significant decrease in symptoms of depression (p < .001) and greater adherence to medical treatment (p < .001) than those in the control group. MiCBT participants also showed a degree of reduction on the HbA1c test than the controls, but no statistically significant between-group effect was found (p < .127). Despite our limitations in the application of the MiCBT program, we conclude that MiCBT is a helpful program for the psychological impairment of patients with Type II Diabetes mellitus